Overview

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

Status:
Active, not recruiting

Trial end date:
2025-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to select the best therapeutic strategy in studying the effectiveness of the association of a short duration hormonal therapy and radiotherapy compared with radiotherapy alone, in patients with a detectable PSA after radical prostatectomy.

Phase:

Phase 2

Details

Lead Sponsor:

UNICANCER

Collaborator:

Ferring Pharmaceuticals